leflunomide has been researched along with Viremia in 12 studies
Leflunomide: An isoxazole derivative that inhibits dihydroorotate dehydrogenase, the fourth enzyme in the pyrimidine biosynthetic pathway. It is used an immunosuppressive agent in the treatment of RHEUMATOID ARTHRITIS and PSORIATIC ARTHRITIS.
leflunomide : A monocarboxylic acid amide obtained by formal condensation of the carboxy group of 5-methyl-1,2-oxazole-4-carboxylic acid with the anilino group of 4-(trifluoromethyl)aniline. The prodrug of teriflunomide.
Viremia: The presence of viruses in the blood.
| Excerpt | Relevance | Reference |
|---|---|---|
| "To describe leflunomide use in the treatment of drug resistant cytomegalovirus retinitis." | 7.85 | Utility of Leflunomide in the Treatment of Drug Resistant Cytomegalovirus Retinitis. ( Goldstein, DA; Jumroendararasame, C; Minkus, CL; Pursell, K; Rifkin, LM, 2017) |
| "TTV DNA load was quantified by PCR in a cross-sectional sample of 79 patients with chronic arthritis on biologic therapy (abatacept, infliximab, rituximab or tocilizumab), 31 patients treated with conventional DMARDs (methotrexate and/or leflunomide), and 54 healthy individuals." | 3.96 | Torque teno virus viremia in patients with chronic arthritis: Influence of biologic therapies. ( Aguado, JM; Albert, E; Fernández-Ruiz, M; González-Álvaro, I; Martín-López, M; Navarro, D; Pablos, JL; Rodríguez, E, 2020) |
| "To describe leflunomide use in the treatment of drug resistant cytomegalovirus retinitis." | 3.85 | Utility of Leflunomide in the Treatment of Drug Resistant Cytomegalovirus Retinitis. ( Goldstein, DA; Jumroendararasame, C; Minkus, CL; Pursell, K; Rifkin, LM, 2017) |
| " Patients with significant viremia and/or biopsy-proven BKPVAN were treated with immunosuppression reduction and leflunomide." | 3.85 | Stabilization of renal function after the first year of follow-up in kidney transplant recipients treated for significant BK polyomavirus infection or BK polyomavirus-associated nephropathy. ( Bodson-Clermont, P; Cardinal, H; Fortin, MC; Girardin, C; Hébert, MJ; Lévesque, R; Pâquet, MR; Renoult, E; Simard-Meilleur, MC; St-Louis, G, 2017) |
| "This analysis demonstrates for the first time that, used in a stepwise fashion, ciprofloxacin and leflunomide are effective and safe treatments for BK viremia in PRTR." | 3.80 | A novel treatment regimen for BK viremia. ( Cheam, H; Ettenger, RB; Malekzadeh, MH; Tsai, EW; Zaman, RA, 2014) |
| "BK viremia and nephritis are increasing problems in renal transplant recipients." | 2.43 | BK virus nephritis after renal transplantation. ( Hariharan, S, 2006) |
| "Treatment with leflunomide was started after a mean of 1." | 1.51 | Clinical utility of leflunomide for BK polyomavirus associated nephropathy in kidney transplant recipients: A multicenter retrospective study. ( Bouvier, N; Caillard, S; Conrad, A; Duquennoy, S; Fafi-Kremer, S; Hurault De Ligny, B; Keller, N; Morelon, E; Moulin, B, 2019) |
| Timeframe | Studies, this research(%) | All Research% |
|---|---|---|
| pre-1990 | 0 (0.00) | 18.7374 |
| 1990's | 0 (0.00) | 18.2507 |
| 2000's | 1 (8.33) | 29.6817 |
| 2010's | 9 (75.00) | 24.3611 |
| 2020's | 2 (16.67) | 2.80 |
| Authors | Studies |
|---|---|
| Kurašová, E | 1 |
| Štěpán, J | 1 |
| Krejčí, K | 1 |
| Mrázek, F | 1 |
| Sauer, P | 1 |
| Janečková, J | 1 |
| Tichý, T | 1 |
| Keller, N | 1 |
| Duquennoy, S | 1 |
| Conrad, A | 1 |
| Fafi-Kremer, S | 1 |
| Morelon, E | 1 |
| Bouvier, N | 1 |
| Moulin, B | 1 |
| Hurault De Ligny, B | 1 |
| Caillard, S | 1 |
| Martín-López, M | 1 |
| Albert, E | 1 |
| Fernández-Ruiz, M | 1 |
| González-Álvaro, I | 1 |
| Rodríguez, E | 1 |
| Aguado, JM | 1 |
| Navarro, D | 1 |
| Pablos, JL | 1 |
| Dunn, JH | 1 |
| Weinberg, A | 1 |
| Chan, LK | 1 |
| Mandava, N | 1 |
| Levi, ME | 1 |
| Olson, JL | 1 |
| Zaman, RA | 1 |
| Ettenger, RB | 1 |
| Cheam, H | 1 |
| Malekzadeh, MH | 1 |
| Tsai, EW | 1 |
| Gagneux-Brunon, A | 1 |
| Pillet, S | 1 |
| Laurent, B | 1 |
| Mariat, C | 1 |
| Michalet, M | 1 |
| Lucht, F | 1 |
| Botelho-Nevers, E | 1 |
| Rifkin, LM | 1 |
| Minkus, CL | 1 |
| Pursell, K | 1 |
| Jumroendararasame, C | 1 |
| Goldstein, DA | 1 |
| Ambrose, T | 1 |
| Sharkey, LM | 1 |
| Louis-Auguste, J | 1 |
| Rutter, CS | 1 |
| Duncan, S | 1 |
| English, S | 1 |
| Gkrania-Klotsas, E | 1 |
| Carmichael, A | 1 |
| Woodward, JM | 1 |
| Russell, N | 1 |
| Massey, D | 1 |
| Butler, A | 1 |
| Middleton, S | 1 |
| Yang, D | 1 |
| Keys, B | 1 |
| J Conti, D | 1 |
| Foulke, L | 1 |
| Stellrecht, K | 1 |
| Cook, L | 1 |
| Lopez-Soler, RI | 1 |
| Simard-Meilleur, MC | 1 |
| Bodson-Clermont, P | 1 |
| St-Louis, G | 1 |
| Pâquet, MR | 1 |
| Girardin, C | 1 |
| Fortin, MC | 1 |
| Cardinal, H | 1 |
| Hébert, MJ | 1 |
| Lévesque, R | 1 |
| Renoult, E | 1 |
| Butts, RJ | 1 |
| Uber, WE | 1 |
| Savage, AJ | 1 |
| Hariharan, S | 1 |
| Trial | Phase | Enrollment | Study Type | Start Date | Status | ||
|---|---|---|---|---|---|---|---|
| BK Viremia and BK Virus Nephropathy Post Kidney Transplant Comparison of New Practices With Traditional Approach: A Combined Retrospective Chart Review and Prospective Observational Study[NCT02758288] | 0 participants (Actual) | Observational | 2015-09-30 | Withdrawn | |||
| [information is prepared from clinicaltrials.gov, extracted Sep-2024] | |||||||
2 reviews available for leflunomide and Viremia
| Article | Year |
|---|---|
JC polyomavirus nephropathy, a rare cause of transplant dysfunction: Case report and review of literature.
Topics: Biopsy; BK Virus; Creatinine; Graft Rejection; Humans; Immunoglobulins, Intravenous; Immunosuppressi | 2017 |
BK virus nephritis after renal transplantation.
Topics: Antibodies, Viral; Antiviral Agents; BK Virus; Cidofovir; Cytosine; DNA, Viral; Graft Survival; Huma | 2006 |
10 other studies available for leflunomide and Viremia
| Article | Year |
|---|---|
Current Status, Prevention and Treatment of BK Virus Nephropathy.
Topics: BK Virus; Humans; Immunosuppressive Agents; Kidney Diseases; Kidney Transplantation; Leflunomide; Po | 2022 |
Clinical utility of leflunomide for BK polyomavirus associated nephropathy in kidney transplant recipients: A multicenter retrospective study.
Topics: Adult; Aged; Female; Graft Rejection; Humans; Immunosuppressive Agents; Kidney; Kidney Diseases; Kid | 2019 |
Torque teno virus viremia in patients with chronic arthritis: Influence of biologic therapies.
Topics: Abatacept; Adult; Aged; Antibodies, Monoclonal, Humanized; Antirheumatic Agents; Arthritis; Biologic | 2020 |
Long-term suppression of multidrug-resistant cytomegalovirus retinitis with systemically administered leflunomide.
Topics: Administration, Oral; Adult; Antiviral Agents; Cytomegalovirus; Cytomegalovirus Retinitis; Drug Resi | 2013 |
A novel treatment regimen for BK viremia.
Topics: Adolescent; BK Virus; Child; Ciprofloxacin; Female; Fluoroquinolones; Glomerular Filtration Rate; Hu | 2014 |
A case of BK virus nephropathy in a stem cell transplant recipient: a rare or under-recognized cause for Acute Kidney injury.
Topics: Acute Kidney Injury; Anti-Bacterial Agents; BK Virus; Ciprofloxacin; Cord Blood Stem Cell Transplant | 2015 |
Utility of Leflunomide in the Treatment of Drug Resistant Cytomegalovirus Retinitis.
Topics: Administration, Oral; Aged; Antiviral Agents; Cytomegalovirus; Cytomegalovirus Retinitis; Drug Resis | 2017 |
Cytomegalovirus Infection and Rates of Antiviral Resistance Following Intestinal and Multivisceral Transplantation.
Topics: Adult; Aged; Antiviral Agents; Cytomegalovirus Infections; Drug Resistance, Viral; Female; Foscarnet | 2016 |
Stabilization of renal function after the first year of follow-up in kidney transplant recipients treated for significant BK polyomavirus infection or BK polyomavirus-associated nephropathy.
Topics: Adult; Allografts; Antiviral Agents; Biopsy; BK Virus; DNA, Viral; Female; Follow-Up Studies; Glomer | 2017 |
Treatment of BK viremia in a pediatric heart transplant recipient.
Topics: Antiviral Agents; BK Virus; Child; Female; Graft Rejection; Heart Transplantation; Humans; Immunosup | 2012 |